ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.0181211508101519 -0.15565025
NSC 724435 Null 0.0181211508101519 -0.20521682
NSC 746687 (2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile 0.0181211508101519 -0.18891385
NSC 748903 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a,4a-diol] 0.0181211508101519 -0.05734895
NSC 9598 3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride 0.0181211508101519 -0.22249189
NSC 335791 3-Azabicyclo[3.2.2]nonane-3-carbothioic acid, [1-(2-pyridinyl)butylidene]hydrazide 0.0187206825450445 -0.16157101
NSC 128635 Null 0.0208632511155817 -0.00039092805
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0208632511155817 -0.18123816
NSC 176323 Camptothecin Derivative 0.0208632511155817 0.012800173
NSC 287069 Epicorazine A 0.0208632511155817 -0.31071014
Total:57  Current:20    [First] [Prev] [Next] [Last]